IBDEI0YS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15512,0)
 ;;=90636^^86^856^3^^^^1
 ;;^UTILITY(U,$J,358.3,15512,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15512,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,15512,1,3,0)
 ;;=3^Hepatitis A & B Combination Vaccine
 ;;^UTILITY(U,$J,358.3,15513,0)
 ;;=4155F^^86^856^5^^^^1
 ;;^UTILITY(U,$J,358.3,15513,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15513,1,2,0)
 ;;=2^4155F
 ;;^UTILITY(U,$J,358.3,15513,1,3,0)
 ;;=3^Hepatitis A Vaccine Previously Received
 ;;^UTILITY(U,$J,358.3,15514,0)
 ;;=G0010^^86^856^6^^^^1
 ;;^UTILITY(U,$J,358.3,15514,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15514,1,2,0)
 ;;=2^G0010
 ;;^UTILITY(U,$J,358.3,15514,1,3,0)
 ;;=3^Hepatitis B Vaccine
 ;;^UTILITY(U,$J,358.3,15515,0)
 ;;=90739^^86^856^7^^^^1
 ;;^UTILITY(U,$J,358.3,15515,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15515,1,2,0)
 ;;=2^90739
 ;;^UTILITY(U,$J,358.3,15515,1,3,0)
 ;;=3^Hepatitis B Vaccine,2 Dose Schedule
 ;;^UTILITY(U,$J,358.3,15516,0)
 ;;=90740^^86^856^9^^^^1
 ;;^UTILITY(U,$J,358.3,15516,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15516,1,2,0)
 ;;=2^90740
 ;;^UTILITY(U,$J,358.3,15516,1,3,0)
 ;;=3^Hepatitis B Vaccine,Dialysis/Immunosupp,3 Dose
 ;;^UTILITY(U,$J,358.3,15517,0)
 ;;=91037^^86^857^5^^^^1
 ;;^UTILITY(U,$J,358.3,15517,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15517,1,2,0)
 ;;=2^91037
 ;;^UTILITY(U,$J,358.3,15517,1,3,0)
 ;;=3^Esoph Imped Funct Test < 1hr
 ;;^UTILITY(U,$J,358.3,15518,0)
 ;;=91038^^86^857^6^^^^1
 ;;^UTILITY(U,$J,358.3,15518,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15518,1,2,0)
 ;;=2^91038
 ;;^UTILITY(U,$J,358.3,15518,1,3,0)
 ;;=3^Esoph Imped Funct Test > 1hr
 ;;^UTILITY(U,$J,358.3,15519,0)
 ;;=91010^^86^857^7^^^^1
 ;;^UTILITY(U,$J,358.3,15519,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15519,1,2,0)
 ;;=2^91010
 ;;^UTILITY(U,$J,358.3,15519,1,3,0)
 ;;=3^Esophageal Manometry Study
 ;;^UTILITY(U,$J,358.3,15520,0)
 ;;=91034^^86^857^10^^^^1
 ;;^UTILITY(U,$J,358.3,15520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15520,1,2,0)
 ;;=2^91034
 ;;^UTILITY(U,$J,358.3,15520,1,3,0)
 ;;=3^Nasal pH probe placement & pH Study
 ;;^UTILITY(U,$J,358.3,15521,0)
 ;;=91030^^86^857^1^^^^1
 ;;^UTILITY(U,$J,358.3,15521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15521,1,2,0)
 ;;=2^91030
 ;;^UTILITY(U,$J,358.3,15521,1,3,0)
 ;;=3^Acid Perfusion of Esophagus
 ;;^UTILITY(U,$J,358.3,15522,0)
 ;;=91013^^86^857^8^^^^1
 ;;^UTILITY(U,$J,358.3,15522,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15522,1,2,0)
 ;;=2^91013
 ;;^UTILITY(U,$J,358.3,15522,1,3,0)
 ;;=3^Esophageal Motility w/ Stim/Perfusion
 ;;^UTILITY(U,$J,358.3,15523,0)
 ;;=91112^^86^857^9^^^^1
 ;;^UTILITY(U,$J,358.3,15523,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15523,1,2,0)
 ;;=2^91112
 ;;^UTILITY(U,$J,358.3,15523,1,3,0)
 ;;=3^GI Tract Pressure,pH,Temp & Transit Study
 ;;^UTILITY(U,$J,358.3,15524,0)
 ;;=91122^^86^857^2^^^^1
 ;;^UTILITY(U,$J,358.3,15524,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15524,1,2,0)
 ;;=2^91122
 ;;^UTILITY(U,$J,358.3,15524,1,3,0)
 ;;=3^Anorectal Manometry
 ;;^UTILITY(U,$J,358.3,15525,0)
 ;;=90912^^86^857^3^^^^1
 ;;^UTILITY(U,$J,358.3,15525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15525,1,2,0)
 ;;=2^90912
 ;;^UTILITY(U,$J,358.3,15525,1,3,0)
 ;;=3^Biofeedback Trng,1st 15 min
 ;;^UTILITY(U,$J,358.3,15526,0)
 ;;=90913^^86^857^4^^^^1
 ;;^UTILITY(U,$J,358.3,15526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15526,1,2,0)
 ;;=2^90913
